| Document |
Document Title |
|
WO/2012/137604A1 |
Provided is a method for producing a diester of a polyhydric alcohol and a fatty acid, the method being provided with a step of obtaining a diester of a polyhydric alcohol and a fatty acid by reacting a monoester of a polyhydric alcohol ...
|
|
WO/2012/129651A1 |
The invention provides compounds of formula (I) with substituents as specified in claim 1 for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceuticals compositions including the compounds or prodrugs of the com...
|
|
WO/2012/126091A1 |
The invention provides compounds for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds. The invention also provides methods of treating di...
|
|
WO/2012/103990A1 |
The present invention relates novel phosphorainidates of monosaccharides of formula (I), wherein R1 is a monosaccharide group selected from A and B: R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16 and X are as defined h...
|
|
WO/2012/097876A1 |
A novel class of cell-penetrating enhancers with unusual chemical structure is herein disclosed. Said cell-penetrating enhancers are non-linear and non peptidic (guanidyl)-oligosaccharidic derivatives, which can be easily obtained accord...
|
|
WO/2012/094752A1 |
A process for producing a natural sweetening enhancer composition comprising at least an Rebaudioside C (RC) extract, said process comprises the steps of preparing a saccharide mother liquor comprising an RC mass content of at least 15%;...
|
|
WO/2012/071508A1 |
A method of preparing a ribofuranose derivative essentially free of pyranose compounds includes a step of contacting a solution of MDR containing MDRP as an impurity in a solvent including methanol and/or tetrahydrofuran with at least on...
|
|
WO/2012/071385A1 |
Disclosed is a method of chlorinating a carbohydrate or derivative thereof, for example, a sucrose-6-ester at the 4,1', and 6' positions, with irreversible removal of HCl formed during the reaction to form the chlorinated carbohydrate or...
|
|
WO/2012/066546A1 |
A new class of pseudo-trisaccharide aminoglycosides having an alkyl group at the 5'' position, exhibiting efficient stop codon mutation readthrough activity, low cytotoxicity and high selectivity towards eukaryotic translation systems ar...
|
|
WO/2012/061927A1 |
The invention provides compounds for selectively inhibiting glycosidases, prodrugs of the compounds, and pharmaceutical compositions including the compounds or prodrugs of the compounds. The invention also provides methods of treating di...
|
|
WO/2012/055146A1 |
Disclosed are C5 or C6 monosaccharide-(E)-3-(furan-2-yl)monoacrylates of formula (1), their preparation methods and uses thereof, wherein R represents C5 or C6 monosaccharide residue. Said compounds are prepared by reacting (E)-3-(furan-...
|
|
WO/2012/057748A1 |
Sugar-acrylic monomers are synthesized to have a carbohydrate moiety linked to an acrylate group. The sugar-acrylic monomers may be polymerized to form polymers, adhesives, hydrogels, and the like. The sugar-acrylic monomers and polymers...
|
|
WO/2012/055010A1 |
The present document describes a neutraceutical, cosmeceuticals, functional food, pharmaceutical, food ingredient, and non-food ingredient compositions comprising sugar maple extract, essential oil compositions comprising oil extracted f...
|
|
WO/2012/036838A2 |
Substituted saccharide compounds, dental compositions comprising substituted saccharide compounds, and methods of using dental compositions are described. In one embodiment, the substituted saccharide amide compound comprises a hydrophob...
|
|
WO/2012/033266A1 |
The present invention relates to a novel artemisinin or deoxoartemisinin-glycolipid hybrid derivatives and antiangiogenic use thereof. The artemisinin or deoxoartemisinin-glycolipid hybrid derivatives of the present invention exhibit two...
|
|
WO/2012/025857A1 |
The invention relates to the cycloalkyl methoxybenzyl phenyl pyran derivatives as Sodium dependent glucose co transporter (SGLT) inhibitors, particularly SGLT2 and method of treating diseases, conditions and/or disorders inhibited by SGL...
|
|
WO/2012/016367A1 |
Trehalose derivatives shown as the general formula (I), preparation methods and uses thereof in the manufacture of medicines for preventing and treating invasion and metastasis of colon cancer 26-L5 cells are disclosed, wherein R is defi...
|
|
WO/2012/006718A1 |
Immunogenic compositions that contain haptens consisting of carbohydrate moieties are useful to induce an immune response to provide antibodies to epitopes contained in CA215 and also to elicit an immune response to cancers expressing th...
|
|
WO/2011/155822A1 |
The present invention relates to the use of trisaccharide derivates comprising a substituted trisaccharide core, which trisaccharide core is fully substituted with fatty acid ester groups, and optionally one or more anionic groups as adj...
|
|
WO/2011/137528A1 |
The invention provides, in part, compounds that are capable of inhibiting a glycosyltransferase, such as a uridine diphospho-N-acetylglucosamine:polypeptide β N-acetylglucosaminyltransferase, an alternative N-acetylglucosaminyltransfera...
|
|
WO/2011/108635A1 |
Disclosed is a supercooling promoting agent comprising a tannin for producing practical water which does not freeze. As the tannin, a hydrolyzable tannin such as 2,3,6-tri-O-galloyl-α,β-D-hamamelose, 1,2,6-tri-O-galloyl-β-D-glucose, o...
|
|
WO/2011/108687A1 |
Disclosed are: a novel Escherichia coli membrane protein insertion factor which is involved in the intake of a protein; and a method for utilizing the Escherichia coli membrane protein insertion factor particularly in the synthesis of a ...
|
|
WO/2011/102123A1 |
Provided is a novel dextrin fatty acid ester which exhibits excellent tack and is useful as a base material for cosmetics and so on. A dextrin fatty acid ester prepared by esterification between a dextrin and a fatty acid component, wher...
|
|
WO/2011/100979A1 |
The present invention relates to a method for preparation of the trisaccharide 6'-0-sialyllactose (formula (I)) or salts thereof as well as intermediates in the synthesis and for the use of 6'-0-sialyllactose salts in pharmaceutical or n...
|
|
WO/2011/097733A1 |
An isolated or purified compound is provided, comprising A- GlcNAc[GlcNAc]-GalNAc-GalNAc-QuiNAc4NAc, wherein A is GIcNAc or GIc. There is further provided a vaccine based on such compound, having particular use to treat or prevent an inf...
|
|
WO/2011/099570A1 |
Disclosed is an AGE production inhibitor or the like, which effectively inhibits the production of an advanced glycation end product (AGE), while having improved biological safety. Specifically disclosed is an AGE production inhibitor or...
|
|
WO/2011/085454A1 |
The present invention provides for novel benzene compounds and saccharide compounds and for the use of said compounds for binding, titration (quantification), removing, purifying or separating the glycoprotein gp120, gp120 comprising vir...
|
|
WO/2011/079494A1 |
Halogenated dideoxy saccharide derivatives with the following general formula I are disclosed, wherein X and R1 - R4 are defined as in the description. It is shown that compounds 1-14 have better effect for inhibiting the growth of many ...
|
|
WO/2011/069334A1 |
Natural occurring inhibitors of cyclin-dependent protein kinase 5 (Cdk5), isolated from the root of Rhodiola rosea are structurally different from the known Cdk inhibitors. They show selectivity among different Cdks and efficacy to inhib...
|
|
WO/2011/068817A1 |
Disclosed herein are compositions that include a blend of sucrose polyesters, wherein each sucrose polyester includes a sucrose moiety and a plurality of fatty acid ester moieties, wherein a percentage range of the combined fatty acid es...
|
|
WO/2011/060807A1 |
The present invention relates to a novel process for producing N-acetyl-D-Glucosamine from Glucosamine hydrochloride. More particularly this invention pertains to a novel and simple environmentally acceptable process for producing glucos...
|
|
WO/2011/045565A1 |
A process for the production of sucrose-6-ester is disclosed. The process comprises, in order, the steps of: (a) providing a first reaction mixture comprising sucrose, a reaction vehicle, and an organotin-based acylation promoter; (b) re...
|
|
WO/2011/045566A1 |
A method for the preparation of a sucrose-6-ester is disclosed. In a first step of the method, sucrose in a polar aprotic solvent is reacted with an organotin-based acylation promoter. The water of reaction is removed at a temperature th...
|
|
WO/2011/021398A1 |
Provided are pyranose derivatives and furanose derivatives, depicted in formulas (I) through (V), of glucose, mannose, psicose, sorbose, tagatose, allose, altrose, gulose, idose, or talose. (In the formulas, M1 represents a specific poly...
|
|
WO/2011/019419A1 |
Tumors can be selectively targeted via compounds provided herein according to the formula, or a pharmaceutically acceptable salt thereof, wherein RA and RB are as defined herein. Tumors can be imaged or targeted for therapeutic treatment...
|
|
WO/2011/016260A1 |
Disclosed is a glycosyl donor reagent comprising a glycosyl donor compound other than a sugar nucleotide. Also disclosed is an enzyme capable of catalyzing a glycosyltransfer reaction that utilizes a glycosyl donor compound other than a ...
|
|
WO/2011/006237A1 |
Compounds of structural formula (I) useful for the treatment or prophylaxis of viral infection, particularly viral influenza are provided Pharmaceutical preparations thereof and methods for their preparation are also described. The thera...
|
|
WO/2011/001913A1 |
Disclosed is a ligand for peroxisome proliferator-activated receptor (PPAR) which originates in a safe food material. Specifically disclosed is a PPAR ligand which comprises, as the active ingredient, a Luffa acutangula L. extract or a n...
|
|
WO/2010/116317A1 |
The present invention relates to a process of synthesis of α-sialyl oligosaccharides and in particular of 6'-sialyllactose and its salts comprising a step of coupling by Koenigs-Knorr reaction under conditions that allow its use on an i...
|
|
WO/2010/114683A1 |
A method of forming a sucrose-6-ester includes in sequence the steps of: a) contacting sucrose with a organotin-based acylation promoter in a solvent in the presence of a base selected from amines and basic alkali metal salts; b) removin...
|
|
WO/2010/094130A1 |
An antimalarial conjugate according to a non-limiting embodiment of the present invention may include a metallocene, a carbohydrate, and an antimalarial agent. The metallocene may include two cyclopentadienyl rings bound to a central met...
|
|
WO/2010/077623A1 |
The present invention provides processes for producing (2S,3R,4R,5S,6R)-5-fluoro-6- hydroxymethyl-2-[4-(4-methoxy-benzyl)-5-trifluoromethyl-1H-p
yrazol-3-yloxy]- tetrahydro-pyran-3,4-diol or a tautomer or hydrate thereof, of high purity ...
|
|
WO/2010/069518A1 |
Suggested is an improved process for making polyol esters with improved colour quality by transesterification of polyols or their alkoxylation products with fatty acid alkyl esters, which is characterised in that the reaction is carried ...
|
|
WO/2010/049451A2 |
The invention relates to C-glycosidic analogues of alpha-galactosylceramids of the general formula (I) having immunostimulating and immunoregulating properties.
|
|
WO/2010/049921A1 |
A disaccharide having the structure (Formula I), and a disaccharide having the structure (Formula II) exhibit immunomodulatory activity.
|
|
WO/2010/051163A1 |
An ester of a sugar and a brominated fatty acid is a useful FR additive for combustible polymers. The brominated FR additives unexpectedly are stable at the extrusion temperatures, and provide excellent flame retardancy to the combustibl...
|
|
WO/2010/050178A1 |
A trehalose compound having high immunopotentiating activity and low toxicity. The trehalose compound is represented by formula (1). (In the formula, X and X' each represents a phenyl, a naphthyl, R1-CHR2- (wherein R1 and R2 each represe...
|
|
WO/2010/046726A1 |
This patent application has as purpose the application/utilization of esters and ethers derived from xylitol, obtained by organic synthesis, as alternative emollient, moisturizing, emulsifier and co-emulsifier and preservatives for pharm...
|
|
WO/2010/021856A2 |
A composition comprising a highly esterified polyol polyester wherein the polyester comprises a polyol residue and a plurality of fatty acids esters, and wherein from about 5% to about 80% of the fatty acid esters contains exactly one pa...
|
|
WO/2010/021857A1 |
A composition comprising a highly esterified polyol polyester wherein the polyester comprises a polyol residue and a plurality of fatty acids esters, and wherein from about 5% to about 80% of the fatty acid esters contains two or more pa...
|
